Navigation Links
Anadys Pharmaceuticals to Present at the Citi Biotech Day
Date:3/25/2009

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at Citi's 4th Annual Biotech Day on Wednesday, April 1, 2009 at 11:20 a.m. EDT (8:20 a.m. PDT). The conference will be held at the 388 Greenwich Street Conference Center in New York City.

Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and an update on its ANA598 clinical program in hepatitis C.

The corporate presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com. Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through April 15, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in t
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
2. Anadys Pharmaceuticals to Present at Bio Investor Forum
3. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
6. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Villanova University Is Taking Their Leading Master of Science in ... ... Tampa, Fla. (PRWEB) December 17, 2009 -- Open enrollment ... program , which is ideal for working professionals whose busy ... of Science in Human Resource Development debuting online in March ...
(Date:12/17/2009)... Over the last few weeks there has ... that is used by e cigarette opposition in an ... Many are questioning the tactics of these groups when ... a safer alternative to tobacco according to several studies, ... reduction specialist around the world. ,, Special interest ...
(Date:12/17/2009)... CITY, Calif., Dec. 17 Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and rapid tests ... today that it has entered the production animal ... Avian Influenza Antigen Test. This is a USDA-licensed ... in chickens, turkeys and ducks. The disposable, non-instrumented ...
(Date:12/17/2009)... -- Researchers from the School of Sport,Exercise and ... the UK are today,encouraging families worldwide to take ... concerning research* that shows two-thirds of people,across the ... (68%), with the,Portuguese being the least likely (71%) ... According to international research ...
(Date:12/17/2009)... communications functions were determining factors. StaffKnex, developers of web-based ... was selected by Lifespace Communities to deliver its software ... ... Cleveland, OH (PRWEB) December ... web-based nurse scheduling and employee communication software, recently announced ...
Breaking Medicine News(10 mins):Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3
... fewer symptoms of anxiety or depression, while children with ... difficulties forming relationships and being accepted by friends. However, ... depression lead to the social problems, or vice versa. ... to contribute to anxiety and depression than the reverse. ...
... for the unpleasant odor of rotten eggs can safely ... function in mice, producing a suspended-animation-like state. In ... General Hospital (MGH) reseachers report that effects seen in ... a reduction in body temperature and include a substantial ...
... Z-Medica Corp Cites First Responder For Saving Life of ... Accident Victim with Severed Femoral Artery, WALLINGFORD, Conn., ... the company,s 2007 Francis X. Hursey,Award to Rockland Paramedic ... use of its breakthrough QuikClot(R) 1st Response(TM) brand,hemostatic agent ...
... The following are,remarks by Kent Hill, USAID Assistant ... Day 2008:, Although a cure for Tuberculosis (TB) ... one of three leading causes of death worldwide due ... year,while HIV/AIDS claims more than two million lives each ...
... 2008 financial guidance, BOSTON, March 24 ... radiology and medical image and information management,solutions, announced ... Joseph,D. Hill to AMICAS, board of directors while ... financial officer. In addition, the company,has promoted Kevin ...
... and prescribe treatment for brain tumors by studying, under ... invasive biopsy or surgery. Now, researchers at UCSD School ... technology has the potential to non-invasively characterize tumors and ... forms of treatment, based on their specific molecular properties. ...
Other Medicine News:Health News:Youth's social problems contribute to anxiety and depression 2Health News:Sewer-gas-induced suspended animation is rapid and reversible 2Health News:NY-Area Paramedic Wins 2007 Francis X. Hursey Award for Heroic Use of QuikClot(R) Blood Clotting Product 2Health News:NY-Area Paramedic Wins 2007 Francis X. Hursey Award for Heroic Use of QuikClot(R) Blood Clotting Product 3Health News:Statement from Kent Hill, USAID Assistant Administrator for Global Health, on the Observance of World Tuberculosis Day 2008 2Health News:Statement from Kent Hill, USAID Assistant Administrator for Global Health, on the Observance of World Tuberculosis Day 2008 3Health News:AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer 2Health News:AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer 3Health News:AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer 4Health News:MRI: A window to genetic properties of brain tumors 2
(Date:12/16/2009)... -- Hospira, Inc. (NYSE: HSP ), a ... announced that it will host a conference call to ... for 2010 on Thursday, Feb. 4, 2010, at 8 ... fourth-quarter and full-year 2009 results earlier that morning, before ... ,, A live webcast of the conference call will ...
(Date:12/16/2009)... EuroPharma, Inc. signs exclusive multi-year ... of super absorbency BCM-95® curcumin and specialized ... The exclusive distribution territory for these clinically-studied ... channel and professional channel, which includes allopathic ... BCM-95® is a highly absorbable curcumin. ...
(Date:12/16/2009)... 16 Boston Scientific Corporation (NYSE: ... Directors has elected Nelda Connors as a Director. ... Electrical and Metal Products division of Tyco International. ... holding several positions in operations and general management. ... number of executive and management capacities with Ford, Chrysler ...
Breaking Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3comScore Announces Availability of comScore ImpactRx Physician Behavioral Measurement 28TM 29 Solution 60540 1comScore Announces Availability of comScore ImpactRx Physician Behavioral Measurement 28TM 29 Solution 60540 2comScore Announces Availability of comScore ImpactRx Physician Behavioral Measurement 28TM 29 Solution 60540 3World Egg Bank Launches Medical Tourism Program With Worlds Largest Egg Donation Fertility Clinic 14691 1World Egg Bank Launches Medical Tourism Program With Worlds Largest Egg Donation Fertility Clinic 14691 2Educational Video Series Released for American Diabetes Month 5929 1Educational Video Series Released for American Diabetes Month 5929 2Educational Video Series Released for American Diabetes Month 5929 3Educational Video Series Released for American Diabetes Month 5929 4
... Anaerobes is the Leading Attribute in Antibiotic Selection, ... Decision ResourcesMALVERN, Pa. and WALTHAM, Mass. , ... Decision Resources find that surveyed physicians will increase ... & Johnson,s Doribax in the next five years ...
... Improve Diagnosis for Children with Cornelia deLange Syndrome-PHILADELPHIA, ... studying a rare genetic disease discovered that a ... keeping chromosomes together also plays an important role ... is disrupted in the multisystem genetic disease Cornelia ...
Other Medicine Technology:Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 2Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 3In Rare Disorder, a Familiar Protein Disrupts Gene Function 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 3In Rare Disorder, a Familiar Protein Disrupts Gene Function 4
... bags under the drape during total knee surgery. ... contact and positioning the leg in flexion, and can ... drape by attaching it to a standard table attachment ... of the drape. It can be attached to the ...
Helps support the femur during femoral fracture fixation and extremity prepping....
Helps protect the chest and shoulders from slumping forward during total hip surgery....
... System is a rigid fixation system for small ... modular instrumentation and a superior screw and plating ... four sizes of true lag screws used for ... OSTEOMED's lag screw design eliminates the need to ...
Medicine Products: